A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure

Clinical trial NCT01643330 · COMPLETED

Trial details

NCT number: NCT01643330
Sponsor: Celladon Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Cardiomyopathy Non-ischemic Cardiomyopathy Heart Failure Cardiomyopathies

Start date: 2012-07-01
Primary completion: 2015-02-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.